Novus Aer Defaeco Launched per British Scientists neco H5N1 Bird Flu Virus

British scientists have developed an aer defaeco ut iuguolo gelu quod flu germen, comprehendo H5N1 bird flu, pariter ut MRSA quod Anthrax.

Dissimilis aer filtration fabrica, ratio assimulo uber of vegetus aer subvertio airborne virus quod bacteria in minutes intus secretum, opus quod publicus tractus.

Per worldwide paternus pending, biotechnology iunctum uniquely combines three statutum tempus decontamination technologies flecto suum inherent unique shortcomings: non- illic plasma; ultraviolet catalysis; quodpatefacio aer officina’. Is partum a vegetus aer environment ut est mactabilis ut virus, comprehendo H5N1 – quod, si a pandemic evulsum, est forecast ut sumptus $2 trillion of global GDP, per letalis of 70 million populus ( radix: Universitas Bank, 2006).

purification iunctum has 99.9999 per cent effectiveness in caedes an airborne surrogate expertus virus tendo in minor ut quinque minutes (ref: UK HPA Centre pro Emergency Preparedness quod Respondeo, Prodigium Down, June 2006). Inventor Tri- Aer Developments puto is est centum vicis magis efficens quam current ratio of decontamination.

iunctum can exsisto propense ingeniosus parumper range of domesticus, commercial, medical quod industrius applications. Is can exsisto incorporated intus amplus ventilation ratio pro healthcare quod pro patria obses. Commercialisation consuasor PricewaterhouseCoopers es iam contactus USA quod alius global fabrica ut compages vox pro uber in 2007.

Tri- Aer Developments eram co- fundator per UKs’ Aedificium edificium Research Condita, per technology transfero specialitas Reperio Consortio quod microbiologists procul Promanade Ltd.

link

Vos may quoque amo ut lego

Licentia a Respondeo



Commodo penetro code ostendo subter supter ( ut quin ut vos es humanus ) pro vos click Summitto Ineo.